Impact of cardiovascular diagnoses on buprenorphine initiation among patients with opioid use disorder

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Veena Manja

Sacramento VA Medical Centre, Mather (United States of America)

4 More presentations in this session

Presentation thumbnail

Association between consistent marijuana use among young adults and the risk of developing coronary artery diseases: a meta-analysis

Miss G. Fraiji Melo (Sao Paulo, BR)

Abstract Slides Video

Presentation thumbnail

Prevalence of substance use disorder among patients hospitalized for heart failure

Doctor V. Manja (Mather, US)

Abstract Slides Video

Presentation thumbnail

Treatment for alcohol use disorder among patients with alcohol use associated heart failure hospitalizations

Doctor V. Manja (Mather, US)

Abstract Slides Video

Presentation thumbnail

Active cutaneous involvement is linked to left ventricular geometry changes in psoriatic arthritis patients

Doctor O. Garza Flores (Monterrey, MX)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular disease in special populations: real-world challenges

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Five-year cardiovascular outcomes in patients with heart failure and opioid-related disorders: a retrospective cohort study

Congress Presentation

Treatment for alcohol use disorder among patients with alcohol use associated heart failure hospitalizations

Congress Presentation

Alcohol use disorder and initiation of oral anticoagulant therapy in patients with atrial fibrillation: a nationwide cohort study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources